InsidersTradesSigma
Track the Xintela AB share price and the full management transaction log of the company, a listed equity based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Xintela AB has logged 4 reports. Market capitalisation: €162.3m. The latest transaction was disclosed on 9 December 2025 (Purchase). Among the most active insiders: Thomas Eldered. Every trade is openly available.
4
Insider Decl.
n/a
Thresholds
€25,695
3 ops.
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 December 2025
Declarations4 total
300,000 shares@ €0.02380.0033% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0026875932FI:A003U534-1
279,245,785 shares0Teckningsrätt/UniträttISIN SE0026875924FI:A003U530-1
577,000 shares@ €0.02370.0063% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0026875932FI:A003U518-1
206,820 shares@ €0.02370.0023% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0026875932FI:A003U477-1
4 of 4 declarations
Acerca de Xintela AB
Xintela AB es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades graves utilizando su tecnología de marcaje celular. Cotiza en el mercado XSTO.